Frequency of homozygous deletion at p16/CDKN2 in primary human tumoursPaul Cairns, David Sidransky, Thomas J. Polascik et al.|Nature Genetics|1995Cited by 646
Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing TitersEshan U. Patel, Oliver Laeyendecker, Evan M. Bloch et al.|Journal of Clinical Microbiology|2020Cited by 198
SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma DonorsSarah E. Benner, Andrew D. Redd, Kirsten Littlefield et al.|The Journal of Infectious Diseases|2020Cited by 118
A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in actionChristine M. Durand, Dorry L. Segev, Wanying Zhang et al.|American Journal of Transplantation|2020Cited by 112
A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipientsAndrew H. Karaba, William A. Werbel, Xianming Zhu et al.|American Journal of Transplantation|2021Cited by 103